High-throughput imaging reveals efflux pump heterogeneity in Escherichia coli, indicating survival strategies under antibiotics.
Understanding how bacterial cells survive antibiotic treatment requires tools capable of resolving dynamic physiological heterogeneity at single-cell resolution. Here, we present a high-throughput, lineage-resolved microfluidic imaging platform for quantifying the expression and spatial distribution of the AcrAB-TolC efflux pump in Escherichia coli during antibiotic exposure. The system is built around a custom-designed multilayer microfluidic device, fabricated using a direct-write photolithography protocol, which ensures uniform delivery of nutrients and antibiotics while confining thousands of individual cells in dead-end trenches. Brightfield imaging provides a label-free, high-temporal-resolution method for tracking cell growth and division, enabling accurate reconstruction of lineages over time. Efflux pump abundance is quantified using GFP-tagged AcrB, while a red fluorescent reporter driven by a constitutive promoter serves as a control to account for growth-dependent fluorescence artifacts. To analyse the sources of heterogeneity in efflux abundance and its consequences for antibiotic response dynamics, we developed a lineage-resolved analytical framework that compares cells of similar replicative age but differing spatial positions, and vice versa. This analysis was made possible by a novel machine-learning-based image processing pipeline, which enables robust cell segmentation, tracking, and lineage reconstruction across multiple fields of view. By extracting time-resolved single-cell data, this platform allows precise dissection of non-genetic variability in efflux activity and its role in determining survival outcomes, offering a powerful foundation for future quantitative studies of bacterial physiology under antibiotic stress.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: